The Next Web
Insilico says its AI-designed lung drug lowered biological age markers in a 42-patient trial
Blood samples from a small lung-disease trial have been run through six independently built ageing clocks, and all six returned the same answer: the patients on the drug looked biologically younger than the patients on placebo. “More…
View original source — The Next Web ↗
Related stories
Bloomberg
BusinessSep 7, 2026 · 1 min
AI-Discovered Drug Reverses Aging Markers in Study, Biotech Says
Bloomberg
The New York Times
TechnologySep 7, 2026 · 1 min
Early Data Indicates an A.I.-Generated Drug Could Slow Aging
The New York Times
Nature
TechnologySep 2, 2026 · 1 min
Can GLP-1 drugs slow ageing? Mouse study shows promise
Nature
Nature
TechnologySep 2, 2026 · 1 min
Late-life semaglutide treatment slows ageing and extends lifespan in female mice
Nature